ABOUT THE EVENT
Date: Tuesday, September 8, 2026 8am–6:10pm PDT
Event Location: San Francisco, California
Step into a day with the leaders driving the future of AI in drug discovery, bringing together scientists, innovators, and decision-makers from across pharma and biotech. That is what the AI in Drug Discovery Xchange San Francisco 2026 offers. This invitation-only, highly curated meeting provides access to senior expertise and the opportunity to build meaningful relationships that can influence data strategy, target discovery, and pipeline acceleration.
Across dedicated tracks including Data Quality, Target Identification, Lead Generation and Optimization, Drug Response Prediction, and Drug Design and Modeling, attendees will explore how artificial intelligence is transforming each stage of the drug discovery process. Discussions span areas such as AI-ready data, generative models, multi-omic integration, predictive analytics, and translating computational insights into clinical impact, all grounded in real-world applications and current industry challenges.
The agenda is designed to maximise interaction and value, combining keynote and spotlight presentations, poster sessions, expert-led roundtables, and pre-scheduled one-to-one meetings. Structured networking throughout the day ensures ample opportunity to exchange insights, benchmark strategies, and identify high-value collaborations.
Taking place in San Francisco on September 9th 2026, this Xchange connects a senior community working at the forefront of AI-enabled drug discovery.
Registration is complimentary for qualified attendees.
